Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.

Preiss, David; Campbell, Ross T; Murray, Heather M; Ford, Ian; Packard, Chris J; Sattar, Naveed; Rahimi, Kazem; Colhoun, Helen M; Waters, David D; LaRosa, John C; Amarenco, Pierre; Pedersen, Terje R; Tikkanen, Matti J; Koren, Michael J; Poulter, Neil R; Sever, Peter S; Ridker, Paul M; MacFadyen, Jean G; Solomon, Scott D; Davis, Barry R; Simpson, Lara M; Nakamura, Haruo; Mizuno, Kyoichi; Marfisi, Rosa M; Marchioli, Roberto; Tognoni, Gianni; Athyros, Vasilios G; Ray, Kausik K; Gotto, Antonio M; Clearfield, Michael B; Downs, John R; McMurray, John J.

Eur Heart J ; 36(24): 1536-46, 2015 Jun 21.

Artigo em Inglês | MEDLINE | ID: mdl-25802390

2.

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.

Boekholdt, S Matthijs; Arsenault, Benoit J; Hovingh, G Kees; Mora, Samia; Pedersen, Terje R; Larosa, John C; Welch, K M A; Amarenco, Pierre; Demicco, David A; Tonkin, Andrew M; Sullivan, David R; Kirby, Adrienne; Colhoun, Helen M; Hitman, Graham A; Betteridge, D John; Durrington, Paul N; Clearfield, Michael B; Downs, John R; Gotto, Antonio M; Ridker, Paul M; Kastelein, John J P.

Circulation ; 128(14): 1504-12, 2013 Oct 01.

Artigo em Inglês | MEDLINE | ID: mdl-23965489

3.

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

Boekholdt, S Matthijs; Arsenault, Benoit J; Mora, Samia; Pedersen, Terje R; LaRosa, John C; Nestel, Paul J; Simes, R John; Durrington, Paul; Hitman, Graham A; Welch, K M A; DeMicco, David A; Zwinderman, Aeilko H; Clearfield, Michael B; Downs, John R; Tonkin, Andrew M; Colhoun, Helen M; Gotto, Antonio M; Ridker, Paul M; Kastelein, John J P.

JAMA ; 307(12): 1302-9, 2012 Mar 28.

Artigo em Inglês | MEDLINE | ID: mdl-22453571

4.

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Sattar, Naveed; Preiss, David; Murray, Heather M; Welsh, Paul; Buckley, Brendan M; de Craen, Anton J M; Seshasai, Sreenivasa Rao Kondapally; McMurray, John J; Freeman, Dilys J; Jukema, J Wouter; Macfarlane, Peter W; Packard, Chris J; Stott, David J; Westendorp, Rudi G; Shepherd, James; Davis, Barry R; Pressel, Sara L; Marchioli, Roberto; Marfisi, Rosa Maria; Maggioni, Aldo P; Tavazzi, Luigi; Tognoni, Gianni; Kjekshus, John; Pedersen, Terje R; Cook, Thomas J; Gotto, Antonio M; Clearfield, Michael B; Downs, John R; Nakamura, Haruo; Ohashi, Yasuo; Mizuno, Kyoichi; Ray, Kausik K; Ford, Ian.

Lancet ; 375(9716): 735-42, 2010 Feb 27.

Artigo em Inglês | MEDLINE | ID: mdl-20167359

5.

C-reactive protein: a new risk assessment tool for cardiovascular disease.

Clearfield, Michael B.

J Am Osteopath Assoc ; 105(9): 409-16, 2005 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-16239491

6.

Hemodynamic effects of osteopathic manipulative treatment immediately after coronary artery bypass graft surgery.

O-Yurvati, Albert H; Carnes, Michael S; Clearfield, Michael B; Stoll, Scott T; McConathy, Walter J.

J Am Osteopath Assoc ; 105(10): 475-81, 2005 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-16314680

7.

Statins: balancing benefits, efficacy and safety.

Clearfield, Michael B.

Expert Opin Pharmacother ; 3(5): 469-77, 2002 May.

Artigo em Inglês | MEDLINE | ID: mdl-11996626

8.

Adult Treatment Panel III: do we really need another set of cholesterol guidelines?

Clearfield, Michael B.

J Am Osteopath Assoc ; 102(5 Suppl 1): S6-11, 2002 May.

Artigo em Inglês | MEDLINE | ID: mdl-12046681

9.

The national cholesterol education program adult treatment panel ill guidelines.

Clearfield, Michael B.

J Am Osteopath Assoc ; 103(1 Suppl 1): S1-5, 2003 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-12572622

10.

Underidentification and undertreatment of dyslipidemia.

Clearfield, Michael B.

J Am Osteopath Assoc ; 103(1 Suppl 1): S5-8, 2003 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-12572623

11.

A novel therapeutic approach to dyslipidemia.

Clearfield, Michael B.

J Am Osteopath Assoc ; 103(1 Suppl 1): S16-20, 2003 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-12572626

12.

Weight of the evidence in statin clinical trials: comparing the results.

Clearfield, Michael B.

J Am Osteopath Assoc ; 103(7 Suppl 3): S4-11, 2003 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-12884938

13.

Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.

Clearfield, Michael B; Weis, Stephen E; Willis, John M; Vasenius, Keith Allen; McConathy, Walter J.

J Am Osteopath Assoc ; 102(7): 377-84, 2002 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-12138952

14.

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.

Boekholdt, S Matthijs; Hovingh, G Kees; Mora, Samia; Arsenault, Benoit J; Amarenco, Pierre; Pedersen, Terje R; LaRosa, John C; Waters, David D; DeMicco, David A; Simes, R John; Keech, Antony C; Colquhoun, David; Hitman, Graham A; Betteridge, D John; Clearfield, Michael B; Downs, John R; Colhoun, Helen M; Gotto, Antonio M; Ridker, Paul M; Grundy, Scott M; Kastelein, John J P.

J Am Coll Cardiol ; 64(5): 485-94, 2014 Aug 05.

Artigo em Inglês | MEDLINE | ID: mdl-25082583

15.

Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.

Clearfield, Michael B.

J Am Osteopath Assoc ; 110(4 Suppl 4): S2-6, 2010 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-20453192

16.

Clinical practice characteristics of osteopathic and allopathic primary care physicians at academic health centers: results from the National Ambulatory Medical Care Survey.

Licciardone, John C; Clearfield, Michael B; Guillory, V James.

Acad Med ; 84(6): 744-50, 2009 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-19474550

17.

Overweight and obesity: the pathogenesis of cardiometabolic risk.

Bray, George A; Clearfield, Michael B; Fintel, Dan J; Nelinson, Donald S.

Clin Cornerstone ; 9(4): 30-40; discussion 41-2, 2009.

Artigo em Inglês | MEDLINE | ID: mdl-19789062

18.

Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).

Cui, Yadong; Watson, Douglas J; Girman, Cynthia J; Shapiro, Deborah R; Gotto, Antonio M; Hiserote, Patricia; Clearfield, Michael B.

Am J Cardiol ; 104(6): 829-34, 2009 Sep 15.

Artigo em Inglês | MEDLINE | ID: mdl-19733719

19.

Research funding at colleges of osteopathic medicine: 15 years of growth.

Clearfield, Michael B; Smith-Barbaro, Peggy; Guillory, V James; Cavalieri, Thomas A; Wood, Douglas L; Sharp, Glynda F; Hahn, Marc B.

J Am Osteopath Assoc ; 107(11): 469-78, 2007 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-18057221

20.

Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia--Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR).

Clearfield, Michael B; Amerena, John; Bassand, Jean-Pierre; Hernández García, Hugo R; Miller, Sam S; Sosef, Froukje F M; Palmer, Michael K; Bryzinski, Brian S.

Trials ; 7: 35, 2006 Dec 21.

Artigo em Inglês | MEDLINE | ID: mdl-17184550

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

C-reactive protein: a new risk assessment tool for cardiovascular disease.

Hemodynamic effects of osteopathic manipulative treatment immediately after coronary artery bypass graft surgery.

Statins: balancing benefits, efficacy and safety.

Adult Treatment Panel III: do we really need another set of cholesterol guidelines?

The national cholesterol education program adult treatment panel ill guidelines.

Underidentification and undertreatment of dyslipidemia.

A novel therapeutic approach to dyslipidemia.

Weight of the evidence in statin clinical trials: comparing the results.

Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.

Altering the pathophysiology of atherosclerosis: the multidimensional role of statins.

Clinical practice characteristics of osteopathic and allopathic primary care physicians at academic health centers: results from the National Ambulatory Medical Care Survey.

Overweight and obesity: the pathogenesis of cardiometabolic risk.

Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).

Research funding at colleges of osteopathic medicine: 15 years of growth.

Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia--Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR).